EGFR and non-small cell lung carcinoma: NSCLC can be divided into subclasses based on the presence of driver mutations in proteins such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and Kirsten rat sarcoma virus (KRAS).